Andere talen Novo Nordisk A/S

Aandelen

NOVO B

DK0062498333

Geschatte realtime Cboe Europe Andere beurzen 16:44:54 13-09-2024			Variatie 5 dagen	Verschil t.o.v. 1 jan (%)
922,10 ^DKK	+0,86%		+4,38%	+31,80%

01:57	Eli Lilly investeert $1,8 miljard in Ierse vestigingen om de productie van Alzheimer- en obesitasmedicijnen op te voeren	RE
12/09	NOVO NORDISK : Deutsche Bank ontvangt een koopadvies	ZD

Andere talen

Krijg toegang tot al het nieuws: wees als eerste op de hoogte en reageer voordat de beurs dat doet!

Gratis inschrijven

Abnehmspritze Liraglutid mindert Übergewicht bei Kindern	06:28
Eli Lilly invests $1.8 billion in Ireland sites to scale up Alzheimer's, obesity drug production	01:57
Los datos del medicamento contra la obesidad de Novo Nordisk confirman el optimismo de los inversores -- Market Talk	12/09
Aktien Europa: Kursgewinne vor EZB - US-Chiprally gibt Tech-Werten Auftrieb	12/09
Roche shares drop on side effects result in early-stage obesity pill trial	12/09
Health Care Down on Cyclical Bias -- Health Care Roundup	11/09
Etwas fester - US-Daten sprechen für kleinen Zinsschritt	11/09
Börsen reagieren volatil auf US-Preisdaten - Euro fällt	11/09
Sector Update: Health Care Stocks Narrowly Mixed Premarket Wednesday	11/09
Novo Nordisk's Experimental Obesity Pill Could Be More Effective With Extended Use	11/09
Novo Nordisk Reports Positive Results of Phase 3a Trial of Anti-Obesity Drug Liraglutide in Children	11/09
Estudio revela que fármaco contra la obesidad más antiguo de Novo es seguro y eficaz para los niños	11/09
Weight-loss drug Saxenda effective for kids as young as 6, study shows	11/09
Health Care Up on Defensive Bias -- Health Care Roundup	10/09
Weight-loss market to see 16 new drugs by 2029, report estimates	10/09
Novo Nordisk A/S - share repurchase programme	09/09
Novo Nordisk A/S - share repurchase programme	09/09
Novo Nordisk to present new data from key diabetes and obesity trials at the 60th Annual Meeting of the European Association for the Study of Diabetes	09/09
European Equities Traded in the US as American Depositary Receipts Decline in Friday Trading; Index Set to End Week 3.7% Lower	06/09
Novo Nordisk : va présenter ses avancées dans le diabète	06/09